LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Fapon Highlights Innovative IVD Total Solutions and Localization Services

By LabMedica International staff writers
Posted on 13 Nov 2024
Image
Image

Fapon Biotech (Guangdong, China) is participating in MEDICA 2024 where the company is showcasing its IVD total solutions, including IVD raw materials, reagent services, and open-system instruments. Additionally, the company is introducing its technology transfer and local manufacturing services to best underscore its commitment to quality and customer satisfaction.

At this year’s MEDICA, Fapon is presenting a suite of total solutions across various technology applications, including CLIA, biochemistry, NGS, PCR, LFA, and FIA for both clinical diagnostic labs and POCT scenarios. Leveraging its strong foundation in IVD technologies, Fapon integrates raw materials, reagent services, and open-system instruments into IVD total solutions. This approach ensures reliable, versatile, and seamless services for its IVD partners, particularly local IVD companies and distributors that are establishing or expanding their own IVD production lines. Ultimately, these efforts benefit local hospitals and patients. Fapon's goal is to elevate the portfolios of global IVD manufacturers through technology transfer and local manufacturing.

Fapon's chemiluminescence immunoassay product line being highlighted at the show exemplifies its expertise in IVD total solutions, including the Shine i-series open-system CLIA analyzers for low- to ultra-high-throughput testing, alongside over 70 reagent services for assay such as vitamin D, NT-proBNP, hs-cTnI, PCT and AD. In addition, Fapon is presenting its molecular POCT total solutions and immunofluorescence POCT total solutions, which feature fully automated molecular diagnostic analyzers, immunofluorescence POCT quantitative analyzers, and reagent services, collectively reflecting the company’s commitment to advancing diagnostic technologies for the unique needs of the IVD industry.

Fapon is committed to delivering high-performance IVD core raw materials that meet European market demands. The company’s offerings of animal-origin-free IVD raw materials address stringent market requirements and ethical considerations. Recently, Fapon launched an innovative sandwich immunoassay format for vitamin D using its high-quality raw materials, achieving superior performance and correlation compared to competitive assays. Furthermore, Fapon remains agile in meeting emerging diagnostic needs, providing testing raw materials for prevalent diseases such as SCD, mpox, and H5N1. With a strong focus on respiratory and infectious disease diagnostics, Fapon ensures its customers have access to the high-quality raw materials needed to support effective diagnostics and patient care. At MEDICA 2024, Fapon is showcasing its role as a trusted global partner in the IVD industry while meeting industry professionals, sharing insights, and exploring collaborations that drive innovation forward and improve healthcare outcomes.

Related Links:
Fapon Biotech

Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Gold Member
Hematology Analyzer
Medonic M32B
6 Part Hematology Analyzer with RET + IPF
Mispa HX 88

Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more